Rezolute, Inc.

Rezolute, Inc. - PE Ratioverified

RZLT

Price:

$5.02

Market Cap:

$483.39M

Rezolute, Inc. is a clinical-stage biopharmaceutical company focused on developing groundbreaking therapies for metabolic conditions marked by persistent glucose imbalances, primarily serving the United States market. Its flagship product candidate, RZ358, a human monoclonal antibody, is currently progressing through Phase 2b clinical trials as a potential treatment for congenital hyperinsulinism, an exceptionally rare genetic disorder impacting pediatric patients. The company is also developing RZ402, a powerful and selective plasma kallikrein inhibitor, which is in Phase 1 clinical evaluation for the ongoing management of diabetic macular edema. Founded in 2010, the entity was formerly kno...[Read more]

Industry

Biotechnology

IPO Date

2013-01-14

Stock Exchange

NASDAQ

Ticker

RZLT

The PE Ratio as of June 2026 (TTM) for Rezolute, Inc. (RZLT) is -6.20

According to Rezolute, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.20. This represents a change of 0.03% compared to the average of -6.20 of the last 4 quarters.

Rezolute, Inc. (RZLT) Historical PE Ratio (quarterly & annually)

How has RZLT PE Ratio performed in the past?

The mean historical PE Ratio of Rezolute, Inc. over the last ten years is -2.31. The current -6.20 PE Ratio has changed 26.72% with respect to the historical average. Over the past ten years (40 quarters), RZLT's PE Ratio was at its highest in in the March 2019 quarter at -0.15. The PE Ratio was at its lowest in in the March 2018 quarter at -61.48.

Quarterly (TTM)
Annual

Average

-2.31

Median

-1.81

Minimum

-5.25

Maximum

-0.58

Rezolute, Inc. (RZLT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Rezolute, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 299.40%

Maximum Annual PE Ratio = -0.58

Minimum Annual Increase = -72.76%

Minimum Annual PE Ratio = -5.25

Quarterly (TTM)
Annual
YearPE RatioChange
2025-4.5540.44%
2024-3.2465.30%
2023-1.9637.17%
2022-1.43-72.76%
2021-5.25299.40%
2020-1.31127.02%
2019-0.58-31.00%
2018-0.84-63.56%
2017-2.3038.73%
2016-1.66-53.86%

Rezolute, Inc. (RZLT) Average PE Ratio

How has RZLT PE Ratio performed in the past?

The current PE Ratio of Rezolute, Inc. (RZLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-3.25

5-year avg

-3.29

10-year avg

-2.31

Rezolute, Inc. (RZLT) PE Ratio vs. Peers

How is RZLT’s PE Ratio compared to its peers?

Rezolute, Inc.’s PE Ratio is greater than Tyra Biosciences, Inc. (-12.99), greater than Savara Inc. (-9.82), greater than Geron Corporation (-12.08), less than ProKidney Corp. (-3.33), less than Kura Oncology, Inc. (-2.96), greater than Maravai LifeSciences Holdings, Inc. (-7.17), less than Prime Medicine, Inc. (-2.55), greater than Day One Biopharmaceuticals, Inc. (-20.70), greater than Nanobiotix S.A. (-59.45), less than EyePoint Pharmaceuticals, Inc. (-3.88),

Build a custom stock screener for Rezolute, Inc. (RZLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rezolute, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rezolute, Inc. (RZLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rezolute, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Rezolute, Inc.'s PE Ratio?

How is the PE Ratio calculated for Rezolute, Inc. (RZLT)?

What is the highest PE Ratio for Rezolute, Inc. (RZLT)?

What is the 3-year average PE Ratio for Rezolute, Inc. (RZLT)?

What is the 5-year average PE Ratio for Rezolute, Inc. (RZLT)?

How does the current PE Ratio for Rezolute, Inc. (RZLT) compare to its historical average?